VECTIBIX Side Effects

7019172-8 | Infusion Related Reaction, Interstitial Lung Disease, Metastases To Liver, Respiratory Distress
on Sep 17, 2010 Male patient from JAPAN , 69 years of age, weighting 172.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis against gastrointestinal ulcer, diabetes mellitus, prophylaxis of nausea and vomiting, gastritis prophylaxis and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, interstitial lung disease, metastases to liver, respiratory distress. Vectibix dosage: . During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), BASEN OD (View Basen Od Review and Basen Od Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

7016255-3 | Dyspnoea Exertional, Malignant Neoplasm Progression, Skin Toxicity
Patient was taking Vectibix (View Usage). Patient had the following side effects: dyspnoea exertional, malignant neoplasm progression, skin toxicity on Sep 20, 2010 from GERMANY Additional patient health information: Female patient , 68 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

7013966-0 | Infusion Related Reaction, Interstitial Lung Disease, Metastases To Liver
Adverse event was reported on Sep 17, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis against gastrointestinal ulcer, diabetes mellitus, prophylaxis of nausea and vomiting, gastritis prophylaxis and. Location: JAPAN , 69 years of age, weighting 172.0 lb, After Vectibix was administered, patient had the following side effects: infusion related reaction, interstitial lung disease, metastases to liver. During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), BASEN OD (View Basen Od Review and Basen Od Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

7010742-X | Malignant Neoplasm Progression, Photosensitivity Reaction, Rash, Skin Reaction, Skin Toxicity, Subileus, Thoracic Vertebral Fracture
on Sep 16, 2010 Female patient from GERMANY , weighting 130.1 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, photosensitivity reaction, rash (What is rash?), skin reaction, skin toxicity, subileus, thoracic vertebral fracture. Vectibix dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).


7010019-2 | Acne, Neutropenia
on Sep 15, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: acne (What is acne?), neutropenia. Vectibix dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

7007616-7 | Hepatic Infection, Hypophagia, Mucosal Inflammation, Pain, Pharyngeal Lesion, Skin Reaction
Patient was taking Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: hepatic infection, hypophagia, mucosal inflammation, pain (What is pain?), pharyngeal lesion, skin reaction on Sep 16, 2010 from FRANCE Additional patient health information: Male patient , 50 years of age, . Vectibix dosage: .

7006314-3 | Dermatitis Acneiform, Henoch-schonlein Purpura, Proteinuria, Renal Failure Acute
Adverse event was reported on Sep 10, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis and. Location: JAPAN , 70 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis acneiform, henoch-schonlein purpura, proteinuria, renal failure acute. During the same period patient was treated with ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ). Patient was hospitalized.

7003555-6 | Blood Amylase Increased, Dermatitis
on Sep 11, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: blood amylase increased, dermatitis. Vectibix dosage: .

7001533-4 | Oral Disorder
on Sep 10, 2010 Female patient from JAPAN , 76 years of age, weighting 77.16 lb, was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: oral disorder. Vectibix dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), PANCREAZE (View Pancreaze Review and Pancreaze Label ), DEPAS (View Depas Review and Depas Label ), PURSENNID (View Pursennid Review and Pursennid Label ), LEUCON (View Leucon Review and Leucon Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ).

6994553-7 | Hypophagia, Malaise
Patient was taking Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: hypophagia, malaise on Sep 08, 2010 from JAPAN Additional patient health information: Female patient , 44 years of age, weighting 88.18 lb, was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis and. Vectibix dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), JUZENTAIHOTO (View Juzentaihoto Review and Juzentaihoto Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PAXIL (View Paxil Review and Paxil Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), SERENACE (View Serenace Review and Serenace Label ). Patient was hospitalized.

6988893-5 | Neutropenia
Adverse event was reported on Sep 07, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: JAPAN , 72 years of age, Patient had the following side effects: neutropenia. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6986264-9 | Anaemia, Decreased Appetite, Neutrophil Count Decreased, Rash, Stomatitis
on Sep 01, 2010 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: anaemia, decreased appetite, neutrophil count decreased, rash (What is rash?), stomatitis. Vectibix dosage: . During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), DECADRON (View Decadron Review and Decadron Label ), ALOXI (View Aloxi Review and Aloxi Label ), NORVASC (View Norvasc Review and Norvasc Label ), GASTROM (View Gastrom Review and Gastrom Label ).

6985387-8 | Dyspnoea Exertional, Malignant Neoplasm Progression, Skin Toxicity
on Sep 09, 2010 Female patient from GERMANY , 68 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea exertional, malignant neoplasm progression, skin toxicity. Vectibix dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6979699-1 | Hepatic Function Abnormal, Infusion Related Reaction, Interstitial Lung Disease, Metastases To Liver
Patient was taking Vectibix (View Usage). Patient had the following side effects: hepatic function abnormal, infusion related reaction, interstitial lung disease, metastases to liver on Sep 02, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, weighting 172.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis against gastrointestinal ulcer, diabetes mellitus, prophylaxis of nausea and vomiting, gastritis prophylaxis and. Vectibix dosage: . During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), BASEN OD (View Basen Od Review and Basen Od Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6979455-4 | Blepharitis
Adverse event was reported on Sep 03, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: JAPAN , 67 years of age, After Vectibix was administered, patient had the following side effects: blepharitis. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6976553-6 | Face Oedema
on Sep 01, 2010 Male patient from SPAIN , weighting 165.3 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema. Vectibix dosage: . During the same period patient was treated with ZOLADEX (View Zoladex Review and Zoladex Label ).

6974592-2 | Folliculitis, Rash Pustular
on Aug 31, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: folliculitis, rash pustular. Vectibix dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6974020-7 | Bladder Tamponade, Dermatitis Acneiform, Urinary Bladder Haemorrhage
Patient was taking Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: bladder tamponade, dermatitis acneiform, urinary bladder haemorrhage on Aug 31, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . Patient was hospitalized.

6973639-7 | Conjunctivitis, Dermatitis Acneiform, Ileus, Lacrimation Increased, Periorbital Oedema
Adverse event was reported on Aug 31, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: JAPAN , 59 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: conjunctivitis, dermatitis acneiform, ileus, lacrimation increased, periorbital oedema. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), DALACIN T (View Dalacin-t Review and Dalacin-t Label ), MYSER (View Myser Review and Myser Label ), RINDERON V (View Rinderon-v Review and Rinderon-v Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), VENCOLL (View Vencoll Review and Vencoll Label ), MIYA BM (View Miya-bm Review and Miya-bm Label ), PROTECADIN (View Protecadin Review and Protecadin Label ). Patient was hospitalized.

6973638-5 | Skin Haemorrhage, Skin Toxicity
on Aug 31, 2010 Female patient from BELGIUM , 75 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: skin haemorrhage, skin toxicity. Vectibix dosage: . During the same period patient was treated with MAGNESIUM (View Magnesium Review and Magnesium Label ).

6965212-1 | Chills, Constipation, Convulsion, Dry Skin, Dyspnoea, Erythema, Infection
on Aug 26, 2010 Male patient from GERMANY , weighting 163.1 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: chills, constipation (What is constipation?), convulsion, dry skin, dyspnoea, erythema, infection (What is infection?). Vectibix dosage: . During the same period patient was treated with FENISTIL (View Fenistil Review and Fenistil Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MORPHINE (View Morphine Review and Morphine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6965209-1 | Fatigue, Metastases To Liver, Metastases To Lung
Patient was taking Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, metastases to liver, metastases to lung on Aug 26, 2010 from GERMANY Additional patient health information: Male patient , 54 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: .

6959446-X | Malignant Neoplasm Progression, Photosensitivity Reaction, Rash, Skin Reaction, Skin Toxicity, Subileus, Thoracic Vertebral Fracture
Adverse event was reported on Aug 24, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: GERMANY , weighting 130.1 lb, Patient had the following side effects: malignant neoplasm progression, photosensitivity reaction, rash (What is rash?), skin reaction, skin toxicity, subileus, thoracic vertebral fracture. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6958686-3 | Melaena, Skin Disorder
on Aug 23, 2010 Female patient from JAPAN , 53 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: melaena, skin disorder. Vectibix dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6956922-0 | Henoch-schonlein Purpura, Renal Impairment
on Aug 23, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: henoch-schonlein purpura, renal impairment. Vectibix dosage: . Patient was hospitalized.

6945862-9 | Skin Disorder, Stomatitis
Patient was taking Vectibix (View Usage). Patient had the following side effects: skin disorder, stomatitis on Aug 18, 2010 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6945852-6 | Febrile Neutropenia, Nausea
Adverse event was reported on Aug 18, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: JAPAN , 45 years of age, After Vectibix was administered, patient had the following side effects: febrile neutropenia, nausea (What is nausea?). During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6943443-4 | Dry Mouth, Pyrexia, Stomatitis, White Blood Cell Count Decreased
on Aug 18, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, pyrexia, stomatitis, white blood cell count decreased. Vectibix dosage: . During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6943440-9 | Pyrexia, Rectal Haemorrhage
on Aug 19, 2010 Male patient from AUSTRALIA , weighting 273.4 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: pyrexia, rectal haemorrhage. Vectibix dosage: . During the same period patient was treated with EVEROLIMUS (View Everolimus Review and Everolimus Label ), PEPCIDIN (View Pepcidin Review and Pepcidin Label ), ATACAND (View Atacand Review and Atacand Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6942459-1 | Diarrhoea, Neutropenia, Pulmonary Oedema, Pyrexia, Renal Failure
Patient was taking Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: diarrhoea, neutropenia, pulmonary oedema, pyrexia, renal failure on Aug 24, 2010 from DENMARK Additional patient health information: Male patient , 66 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ZOFRAN (View Zofran Review and Zofran Label ), ATROPIN (View Atropin Review and Atropin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), METFORMIN (View Metformin Review and Metformin Label ), IMODIUM (View Imodium Review and Imodium Label ), FURIX (View Furix Review and Furix Label ). Patient was hospitalized.

6941635-1 | Urinary Retention
Adverse event was reported on Aug 17, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis of nausea and vomiting, diabetes mellitus and. Location: JAPAN , 56 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: urinary retention. During the same period patient was treated with EMEND (View Emend Review and Emend Label ), ACTOS TABLETS 30 (View Actos Tablets 30 Review and Actos Tablets 30 Label ), BASEN TABLETS 0.2 (View Basen Tablets 0.2 Review and Basen Tablets 0.2 Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6940876-7 | Myocardial Infarction
on Aug 17, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: myocardial infarction. Vectibix dosage: .

6939378-3 | Gastrointestinal Inflammation
on Aug 16, 2010 Male patient from JAPAN , 46 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: gastrointestinal inflammation. Vectibix dosage: . During the same period patient was treated with MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6932269-3 | Hypokalaemia, Hyponatraemia, Overdose, Reflux Oesophagitis, Thrombophlebitis
Patient was taking Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, hyponatraemia, overdose, reflux oesophagitis, thrombophlebitis on Aug 16, 2010 from Additional patient health information: Female patient , 71 years of age, was diagnosed with non-small cell lung cancer and. Vectibix dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6930042-3 | Diarrhoea, Neutropenia, Pulmonary Oedema, Pyrexia, Renal Failure
Adverse event was reported on Aug 11, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: DENMARK , 66 years of age, Patient had the following side effects: diarrhoea, neutropenia, pulmonary oedema, pyrexia, renal failure. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), ZOFRAN (View Zofran Review and Zofran Label ), ATROPIN (View Atropin Review and Atropin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), IMODIUM (View Imodium Review and Imodium Label ), FURIX (View Furix Review and Furix Label ). Patient was hospitalized.

6927760-X | Aplasia, Pyrexia
on Aug 11, 2010 Female patient from FRANCE , weighting 180.8 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: aplasia, pyrexia. Vectibix dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ). Patient was hospitalized.

6924061-0 | Hepatic Function Abnormal, Infusion Related Reaction, Interstitial Lung Disease
on Aug 05, 2010 Male patient from JAPAN , 69 years of age, weighting 172.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?), prophylaxis against gastrointestinal ulcer, diabetes mellitus, prophylaxis of nausea and vomiting, gastritis prophylaxis and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, infusion related reaction, interstitial lung disease. Vectibix dosage: . During the same period patient was treated with ELPLAT (View Elplat Review and Elplat Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), BASEN OD (View Basen Od Review and Basen Od Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6924059-2 | Decreased Appetite, Dysstasia
Patient was taking Vectibix (View Usage). Patient had the following side effects: decreased appetite, dysstasia on Aug 05, 2010 from JAPAN Additional patient health information: Female patient , 44 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . Patient was hospitalized.

6924047-6 | Fatigue, Metastases To Liver, Metastases To Lung
Adverse event was reported on May 31, 2010 by a Male patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: GERMANY , 54 years of age, After Vectibix was administered, patient had the following side effects: fatigue, metastases to liver, metastases to lung.

6923047-X | Chills, Cyanosis, Erythema, Skin Warm, Sneezing
on Aug 06, 2010 Male patient from FRANCE , weighting 165.3 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: chills, cyanosis, erythema, skin warm, sneezing. Vectibix dosage: . Patient was hospitalized.

6923045-6 | Malignant Neoplasm Progression, Rash, Skin Toxicity
on May 03, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: malignant neoplasm progression, rash (What is rash?), skin toxicity. Vectibix dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6923044-4 | Dyspnoea, Malignant Neoplasm Progression
Patient was taking Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: dyspnoea, malignant neoplasm progression on Aug 09, 2010 from GERMANY Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . During the same period patient was treated with PARACODIN BITARTRATE TAB (View Paracodin Bitartrate Tab Review and Paracodin Bitartrate Tab Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), NOVALGIN (View Novalgin Review and Novalgin Label ). Patient was hospitalized.

6920122-0 | Fall, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Hypophosphataemia, Joint Dislocation, Rash, Wrist Fracture
Adverse event was reported on Jul 30, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: AUSTRALIA , weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hypocalcaemia, hypokalaemia, hypomagnesaemia, hypophosphataemia, joint dislocation, rash (What is rash?), wrist fracture. During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6919691-6 | Dermatitis Acneiform, Diarrhoea, Malignant Neoplasm Progression, Renal Failure
on Aug 02, 2010 Male patient from GREECE , 67 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient had the following side effects: dermatitis acneiform, diarrhoea, malignant neoplasm progression, renal failure. Vectibix dosage: . Patient was hospitalized.

6917904-8 | Ocular Toxicity
on Aug 04, 2010 Female patient from FRANCE , weighting 160.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: ocular toxicity. Vectibix dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), CETYLPYRIDINIUM CHLORIDE (View Cetylpyridinium Chloride Review and Cetylpyridinium Chloride Label ), CHLOROBUTANOL/POLYVINYL ALCOHOL (View Chlorobutanol/polyvinyl Alcohol Review and Chlorobutanol/polyvinyl Alcohol Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), ZINC (View Zinc Review and Zinc Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.

6917813-4 | Bladder Tamponade, Urinary Bladder Haemorrhage
Patient was taking Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: bladder tamponade, urinary bladder haemorrhage on Aug 02, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . Patient was hospitalized.

6911107-9 | Febrile Bone Marrow Aplasia
Adverse event was reported on Aug 04, 2010 by a Female patient taking Vectibix (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , weighting 160.9 lb, Patient had the following side effects: febrile bone marrow aplasia. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), SOLUPRED (View Solupred Review and Solupred Label ), ZINC GLUCONATE (View Zinc Gluconate Review and Zinc Gluconate Label ), EMEND (View Emend Review and Emend Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), LOCOID (View Locoid Review and Locoid Label ), BICARBONATE (View Bicarbonate Review and Bicarbonate Label ), CETYLPYRIDINIUM CHLORIDE (View Cetylpyridinium Chloride Review and Cetylpyridinium Chloride Label ). Patient was hospitalized.

6911104-3 | Acute Respiratory Distress Syndrome, Cardiac Tamponade, Pulmonary Embolism
on Jul 30, 2010 Male patient from CANADA , weighting 152.1 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). After Vectibix was administered, patient had the following side effects: acute respiratory distress syndrome, cardiac tamponade, pulmonary embolism (What is pulmonary embolism?). Vectibix dosage: .

6908131-9 | Deep Vein Thrombosis
on Aug 02, 2010 Male patient from GERMANY , weighting 174.2 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Vectibix (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Vectibix dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

6906219-X | Diarrhoea, Mouth Ulceration, Neutropenia, Pyrexia, Skin Toxicity, Tumour Marker Test, Weight Decreased
Patient was taking Vectibix (View Usage). Patient had the following side effects: diarrhoea, mouth ulceration, neutropenia, pyrexia, skin toxicity, tumour marker test, weight decreased on Jul 27, 2010 from GREECE Additional patient health information: Male patient , 77 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Vectibix dosage: . During the same period patient was treated with CAMPTOSAR (View Camptosar Review and Camptosar Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).